title: [Pioglitazone].
authors.affiliation: First Department of Medicine, Toyama Medical and Pharmaceutical University.
authors.forename: Masashi
authors.initials: M
authors.lastname: Kobayashi
authors.forename: Minoru
authors.initials: M
authors.lastname: Iwata
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Hiratani
mesh_terms: D000818:Animals; D056486:Chemical and Drug Induced Liver Injury; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000503:physiopathology; D004487:Edema / Q000139:chemically induced; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007333:Insulin Resistance; D050356:Lipid Metabolism; D000077205:Pioglitazone; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology; D013844:Thiazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D045162:Thiazolidinediones; D014157:Transcription Factors / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000502:physiology
chemical_list: D007004:Hypoglycemic Agents; D018160:Receptors, Cytoplasmic and Nuclear; D013844:Thiazoles; D045162:Thiazolidinediones; D014157:Transcription Factors; D014409:Tumor Necrosis Factor-alpha; D000077205:Pioglitazone